1. Introduction
Hen’s egg has long history as a food. It contains a great variety of nutrients to sustain both life and growth. Egg provides an excellent, inexpensive and low calorie source of high-quality proteins. Moreover, Eggs are a good source of several important nutrients including protein, total fat, monounsaturated fatty acids, polyunsaturated fatty acids, cholesterol, choline, folate, iron, calcium, phosphorus, selenium, zinc and vitamins A, B2, B6, B12, D, E and K [1]. Eggs are also a good source of the antioxidant carotenoids, lutein and zeaxanthin [2]. The high nutritional properties of eggs make them ideal for many people with special dietary requirements.
Egg proteins are nutritionally complete with a good balance of essential amino acids which are needed for building and repairing the cells in muscles and other body tissues [3]. Egg proteins are distributed in all parts of the egg, but most of them are present in the egg white and egg yolk amounting to 50% and 40%, respectively. The remaining amount of protein is in the egg shell and egg shell membranes.
In addition to excellent nutritional value, egg proteins have unique biological activities. Hyperimmunized hens could provide a convenient and economic source of specific immunoglobulin in their yolks (IgY) that have been found to be effective in preventing many bacteria and viruses infections [4]. Proteins in the egg white as lysozyme, ovotransferrin, and avidin have proven to exert numerous biological activities. Moreover, a specific protein in eggshell matrix shows unique activity; enhancement of calcium transportation in the human intestinal epithelial cells.
It is well-known that egg proteins are a source of biologically active peptides. Many researches are aiming to unlock the hidden biological functions of peptides hidden in egg proteins. These peptides are inactive within the sequence of parent proteins and can be released during gastrointestinal digestion or food processing and exerting biological activities. Once bioactive peptides are liberated, they may act as regulatory compounds, and exhibit various activities such as anti-hypertensive, bone growth promoting, anticancer or exaggerated antimicrobial activities.
For development of bioactive peptides from parent proteins, following techniques have been conventionally used; the establishment of an assay system of biological activities, hydrolysis of proteins by digestive enzymes, isolation of peptides, determination of structures and synthesis of peptides. Recently, bioengineer technique; synthesis of peptides within egg proteins based on sequence similarities of peptides having known biological activity, has been used. The functional characteristics of either natural or modified egg proteins and the use of eggs components as “functional ingredients” are relatively new applications. A truly impressive volume of researches is now available for the egg industry to apply these new applications. Herein, some aspects concerning biologically functional egg proteins or peptides, biochemical and physiological properties as well as possible applications of egg proteins or peptides are discussed.
2. Egg yolk bio proteins
The major portion of egg yolk exists as lipoproteins, which can be separated by centrifugation into a plasma fraction (which remains soluble) and a granular fraction (which precipitates). Lipovitellenin, lipovitellin, phosvitin, livetin, yolk immunoglobulins (IgY), and some minor components have been isolated and identified in egg yolk.
2.1. Lipoproteins
Low density lipoprotein (LDL), which contains between 80 and 90% lipids, characterized by its emulsifying capacity. LDL is the major protein in egg yolk, accounting for 70% of yolk proteins. When LDL is treated with ether, residual fraction is referred to lipovitellenin containing 40% lipid. [5]. Shinohara et al. (1993) studied the effect of some constituents of egg yolk lipoprotein on the growth and IgM production of human-human hybridoma cells and other human-derived cells [6]. LDL-rich fractions were found to enhance the growth and IgM secretion of HB4C5 cells. The promoting activity was found in the commercial LDL.
High density lipoprotein (HDL) or lipovitellin comprise about one sixth of egg yolk solids in the granular yolk proteins. It has a molecular weight of 4X105 and composed of 80% protein and 20% lipid. HDL exists as a complex with a phosphoprotein referred to phosvitin [5]. The addition of one or two eggs a day to a healthy person's diet does not adversely affect lipoprotein levels, and can actually increase plasma HDL levels [1].
2.2. Phosvitin
The name phosvitin comes from both its high phosphorus content (10%) and its source in the egg yolk. The emulsification properties of phosvitin, particularly emulsion-stabilizing activity, were found to be higher than those of other food proteins. Phosvitin is water insoluble but under low ionic strength and acidic conditions, it becomes soluble and can become complex with various metal ions (
2.3. Vitamin-binding protein
A riboflavin-binding protein exists in the egg yolk. It is a hydrophilic phosphoglycoprotein with a molecular weight of 3.6x106 Da, and it can conjugate one mole of riboflavin per mole of apoprotein. Also, biotin and cobalamin-binding proteins could be found in egg yolk.
2.4. Livetin
Livetin is a water-soluble, non-lipid, globular glycoprotein, which is immunologically analogous to the plasma proteins of mammals. α-Livetin is analogous to serum albumin, β-livetin to 2-glycoprotein and γ-livetin to γ-globulin [10]. Most of the research effort has been focused on the immune proteins found in the egg yolk (IgY). Recent advances in IgY technology will be discussed.
2.5. Egg yolk immunoglobulin (IgY)
Immunoglobulin from yolk (IgY) is the major antibody found in hen eggs. In 1893, Klemperer first described the acquisition of passive immunity in birds, by demonstrating the transfer of immunity against tetanus toxin from the hen to the chick [11]. Three immunoglobulin classes analogues to the mammalian immunoglobulin classes; IgA, IgM, and IgG, have been shown to exist in chicken. In the egg, IgA and IgM are present in the egg white, while IgG is present in the egg yolk [12]. IgG in egg yolk has been referred to as IgY to distinguish it from its mammalian counterpart [13].
The concentration of IgY in the yolk is essentially constant (10-20 mg/mL) through the oocyte maturation. Approximately 100-400 mg IgY is packed in an egg. The concentration of IgY in the yolk is 1.23 times to the serum concentration [14]. A delay of 3 to 4 days is observed for the appearance of specific IgY in yolk after first appearance of specific IgG in the serum of a hen.
2.5.1. Structure and Characteristics of Avian IgY Versus Mammalian IgG
2.5.2. Applications and uses of IgY
Oral administration of antibodies specific to host pathogens is an attractive approach to establish protective immunity, especially against gastrointestinal pathogens both in human and animals. Eggs are normal dietary components and there is practically no risk of toxic side effects of IgY given orally. As mentioned above, IgY does not activate mammalian complement system nor interact with mammalian Fc-receptors that could mediate inflammatory response in the gastrointestinal tract.
On the basis of these facts, IgY has been used for suppression of growth of food-bone pathogens [11]. Whole egg yolks and water soluble fractions were prepared from the egg of the hens that had been immunized with pathogens such as E. coli O157:H7, Salmonella enteritidis, Salmonella typhimurium, Campylobacter jejuni, Staphylococcus aureus, and Listeria monocytogenes. It has been demonstrated that pathogen-specific IgY is bound to the surface of bacteria, resulting in structural alterations of cell wall and consequently kills bacteria. Sarker et al. (2001) performed a study for children with proven rotavirus diarrhea. The patients were treated with IgY from the eggs of chickens immunized with human rotavirus strains [22]. The treatment moderated diarrhea, which was characterized by an earlier clearance of rotavirus from the stools. Recently, IgY has been applied to cancer therapy. Hens were immunized with an antigen purified from human stomach cancer cells. The purified IgY recognized gastrointestinal cancer cells. Conjugation of antibodies and drugs may be an important agent for cancer treatment [23].
These IgY treatments have been shown to provide a safer, more efficient and less expensive method than those using conventional mammalian antibiotics for managing disease-causing pathogens. Recently, successful progresses in industrialization of IgY has been achieved in Japan, where IgY as a bioactive ingredient in food, nutraceuticals, cosmetics and other sectors is applied. The followings are the most recent applications.
2.5.2.1. Anti-Helicobacter pylori IgY
The three different studies demonstrated that administration of a specially designed yogurt with highly specific antibodies from egg yolk could effectively decreases number of
The use of probiotics for the suppression of H. pylori in humans has been studied by some investigators [33, 34]. However, none of these studies were able to show a significant suppression of H. pylori in humans, and others showed a slight but no significant trend toward a suppressive effect of drinking yogurt containing specific lactic acid bacteria. Anti-H. pylori effect of yogurt containing specific lactic acid bacteria has been examined. However, no significant reduction of H. pylori in human stomach has been observed, although trend for decrease was observed [35, 36].
The use of IgY against a pathogenic factor of
These findings opened new gate of applications of IgY-urease against
2.5.2.2. Anti-Streptococcus mutans IgY
Dental caries is still one of the most widespread diseases of mankind. Human are frequently infected with cariogenic microorganisms in early life. The cariogenic microorganisms survive in dental biofilm and can emerge under favorable environmental condition and consequently cause dental disease [39].
2.5.2.3. Anti-Influenza virus IgY (Anti-influenza biofilter)
Influenza caused by a virus is called the influenza virus. Influenza or "flu" is an infection of the respiratory tract that can affect millions of people every year. It is highly contagious and occurs mainly in the late fall, winter, or early spring. Influenza is spread from person-to-person through mists or sprays of infectious respiratory secretions caused by coughing and sneezing. Influenza affects all age groups and causes severe illness, loss of school and work, and complications such as pneumonia, hospitalization, and death.
Recently, specific anti-influenza IgY was successfully produced from hens immunized with inactivated influenza virus strain. This specific IgY significantly reacts virus in vitro [44]. Subsequently, an anti-influenza IgY biofilter which trap the influenza virus has been developed by Daikin Environment Laboratories, Japan, a research arm of Daikin Industries, in cooperation with five Japanese research institutions. It was found that 99.99% of the influenza virus sprayed over the biofilter was captured within 10 minutes. An air cleaner with anti-influenza filter is recently launched in Japan (Figure 5 and 6). Moreover, a facemask with anti-influenza IgY was developed and will be available in the Japanese market.
2.5.2.4. Future prospects of IgY applications
Many research activities and proposals are going on in order to provide new applications for IgY technology. An anti-
3. Egg yolk bio peptides
Recently, it has become clear that proteins are a source for biologically active peptides. These peptides are inactive within the sequence of parent protein and can be released during gastrointestinal digestion or food processing. Egg yolk proteins could be an important source of bioactive peptides. The resultant peptides could show biologically new function with improved stability and/or solubility. In this section, some biologically functional egg yolk derived peptides are introduced and their underlying mechanisms are discussed.
3.1. Lipovitellenin peptide
Vitellenin is the apoprotein of lipovitellenin. Digestion of vitellenin with pronase gives two glycopeptides. Glycopeptide A has high content of sialic acid and glycopeptide B contains most of the carbohydrates of vitellenin but devoid of sialic acid (N-Acetylneuraminic acid). Sialic acid is naturally occurring carbohydrate with numerous biological functions, including blood protein half-life regulation, variety of toxin neutralization, regulation of cellular adhesion and glycoprotein lytic protection.
3.2. Phosvitin peptide
Phosvitin phosphopeptides are new functional bioactive peptides derived from egg yolk with molecular masses of 1-3 kDa prepared from tryptic hydrolysate by partial dephosphorylation [46]. The phosvitin phosphopeptides were shown to be effective for enhancing the calcium binding capacity and inhibiting the formation of insoluble calcium phosphate. The results suggest a potential application of phosvitin peptides as novel functional peptides for the prevention of osteoporosis.
3.3. Egg yolk bone peptides (Bonepep®)
Hen egg turns into a full skeleton chick within 3 weeks; based on this fact, some investigations were carried out to explore the biologically active substances in hen egg that would initiate and enhance bone growth. It has been found that a specific yolk water-soluble protein (YSP) has a bone growth promotion activity
4. Egg white bio proteins
Well-known biological functions of egg white proteins are the prevention of microorganisms’ penetration into the yolk and supply of nutrients to the embryo during the late stages of development. Most of the egg white proteins appear to possess antimicrobial properties or certain physiological functions to interfere with the growth and spread of invading microorganisms.
Most of egg white proteins are soluble and can easily be isolated. Egg white contains approximately 40 different proteins. Egg white proteins possess unique functional properties, such as antimicrobial, enzymatic and anti-enzymatic, cell growth stimulatory, metal binding, vitamin binding, and immunological activities [50].
4.1. Ovalbumin
Ovalbumin is a predominant protein contributing to the functional properties of egg white [51]. Ovalbumin is a monomeric phosphoglycoprotein with a molecular weight of 44.5 kDa and an isoelectric point of 4.5. Ovalbumin is a key reference protein in biochemistry. As a carrier, stabilizer, blocking agent or standard, highly purified ovalbumin has served the fundamentalists as well as the food industry. It has long been the subject of physical and chemical studies as a convenient protein model.
It is believed that ovalbumin, especially its unphosphorylated form, serves as a source of amino acids for the developing embryo. Despite the intensive investigations undertaken on ovalbumin, its function remains largely unknown. Ovalbumin is the only egg white protein which contains free sulfhydryl groups. The complete amino acid sequence of hen ovalbumin (which comprises 385 residues) and its crystal structure have been reported [52]. The unexpected finding that this protein belongs to the serpin superfamily has stimulated new interest in the structure and function of ovalbumin. The serpins are a family of more than 300 homologous proteins with diverse functions found in animals, plants, insects and viruses, but not in prokaryotes [53]. They include the major serine protease inhibitors of human plasma that control enzymes of the coagulation, fibrinolytic, complement and kinin cascades, as well as proteins without any known inhibitory properties such as hormone binding globulins, angiotensinogen and ovalbumin [54].
4.2. Ovotransferrin
Ovotransferrin (also known as conalbumin) has been identified as the iron-binding protein from avian egg white. Ovotransferrin, which constitutes 12% of the egg white protein, has a molecular weight of 77.7 kDa and a pI of about 6.1. It contains 686 amino acid residues and has 15 disulfide bridges [55]. It is glycosylated and contains a single glycan chain (composed of mannose and N-acetylglucosamine residues) in the C-terminal domain. Ovotransferrin is a neutral glycoprotein synthesized in the hen oviduct and deposited in the albumen fraction of eggs. Furthermore, it has two similar domains in N and C terminal regions, each one binding one atom of transition metal (Fe+++, Cu++, Al+++) very tightly and specifically [55]. It is implicated in the transport of iron in a soluble form to the target cells. The recognition of transferrin molecules by the target cells is mediated by membrane-bound transferrin receptors [56]. The significant structural similarities between lactoferrin and ovotransferrin justify the similarity of their biological roles. Ovotransferrin can be used as a nutritional ingredient in iron fortified products such as iron supplements, iron-fortified mixes for instant drinks, sport bars, protein supplements and iron-fortified beverages.
There is also extensive evidence of an antibacterial effect of ovotransferrin based on iron deprivation, iron being an essential growth factor for most microorganisms. The high affinity of transferrins for iron means that, in the presence of unsaturated transferrin (apotransferrin), iron will be sequestered and rendered unavailable for the growth of microorganisms.
4.3. Lysozyme
The name lysozyme was originally used to describe an enzyme which had lytic action against bacterial cells. Lysozyme is one of the oldest egg components to be utilized commercially after it was discovered by Alexander Fleming in 1922. It is a bacteriolytic enzyme commonly found in nature and is present in almost all secreted body fluids and tissues of humans and animals. It has also been isolated from some plants, bacteria and bacteriophages. Avian egg white is a rich and easily available source of lysozyme.
The lysozyme content of a laying hen’s blood is 10-fold higher than in mammals because it is being transferred to the egg white. Lysozyme constitutes approximately 3.5% of hen egg white [50]. Egg white lysozyme consists of 129 amino acid residues with a molecular weight of 14.4 kDa. Because of its basic character, lysozyme binds to ovomucin, transferrin or ovalbumin in egg white [58]. In nature, lysozyme is found mainly as a monomer but it has been reported to also exist as a reversible dimer, which can be evoked by pH, concentration and/or temperature-dependent phase transition of the molecule.
It has long been believed that lysozyme’s antimicrobial action could only be attributed to its catalytic effect on certain Gram-positive bacteria, by splitting the bond between N-acetylmuramic acid and N-acetyl-glucosamine of peptidoglycan in the bacterial cell wall [59]. Beside this well-known inactivation mechanism, a non enzymatic antibacterial mode of action of lysozyme was achieved by denatured form of lysozyme without enzymatic action.
Lysozyme demonstrates antimicrobial activity against a limited spectrum of bacteria and fungi [60]. However, the antimicrobial activity of lysozyme is greater for certain Gram-positive bacteria. On the other hand, Gram-negative bacteria are less susceptible to the bacteriolytic action of the enzyme [61]. The cell walls of different bacteria show varying degrees of susceptibility to digestion with hen egg white lysozyme. The walls of
4.3.1. Molecular modification for functional improvement
4.3.2. Applications
The bacteriostatic and bactericidal properties of lysozyme have been used to preserve various food items, as well as in pharmacy, medicine and veterinary medicine.
In cheese making, lysozyme has been used to prevent growth of
Regardless of the direct bacteriolytic action, many other biological functions of lysozyme have recently been reported. These include anti-viral action by forming an insoluble complex with acidic viruses, enhanced antibiotic effects, anti-inflammatory and anti-histaminic actions, direct activation of immune cells and anti-tumor action [74-77].
4.4. Ovomucoid
Ovomucoid is a glycoprotein with heat stable trypsin inhibitor activity. Ovomucoid, which constitutes about 11% of the egg white protein, has a molecular weight of approximately 28 kDa and a pI of 4.1. It has nine disulfides and no free sulfydryl groups. The molecule consists of three tandem domains, each of which is homologous to pancreatic secretory trypsin inhibitor (Kazal-type). It has a putative reactive site for the inhibition of serine proteases. A large proportion of the carbohydrate present in this glycoprotein (about 25%
4.5. Ovomucin
Ovomucin comprises 1.5-3.5% of the total egg white solids. It is a highly viscous glycoprotein with an extremely large molecular weight (8300-23000 kDa). The specific jellying property of egg white is attributed to ovomucin. It consists of two subunits; α-subunit and a β-subunit which are bound by disulfide bonds. The biological function of ovomucin is shown to inhibition of haemagglutination by viruses. Its affinity with viruses such as bovine rotavirus, hen Newcastle disease virus and human influenza virus was already proved [80]. Moreover, the β-subunit from ovomucin was shown to have a cytotoxic effect on the cultured tumor cells [81].
4.6. Avidin
Avidin is a strongly basic glycoprotein synthesized in the hen oviduct and deposited in the albumen fraction of eggs. Avidin is a tetrameric protein, composed of subunits of identical amino acid composition and sequence (15.6 kDa and 128 amino acids each). Avidin is a trace component (0.05%) of egg white, but it has been well studied because of its ability to tightly and specifically bind biotin, one of Vitamin B group. Each subunit of avidin binds to a molecule of biotin. The high affinity of avidin for biotin has been widely used as a biochemical tool in molecular biology, affinity chromatography, molecular recognition and labeling, Enzyme Linked Immuno Sorbent Assay (ELISA), histochemistry and cytochemistry [82].
4.7. Ovoglobulin
In early studies, six globulin fractions were thought to be present in egg white. They are macroglobulin, ovoglobulins G1, G2 and G3 and two other globulins. However, the two globulins were later classified as ovoinhibitors and ovoglobulin G1 was identified as lysozyme. Currently, the name ovoglobulin is given only to ovoglobulins G2 and G3, which have molecular weights of 36 and 45 kDa, respectively. The biological function of these proteins has not been clearly elucidated, but they appear to be important in the foaming capacity of egg white [5].
4.8. Ovomacroglobulin
Ovomacroglobulin is the second largest egg glycoprotein after ovomucin and its molecular weight is 760-900 kDa. Ovomacroglobulin, like ovomucin, has the ability to inhibit hemagglutination [5].
4.9. Ovoflavoprotein
Ovoflavoprotein is acidic protein with a molecular weight of 32-36 kDa, and contains a carbohydrate moiety (14%) made up of mannose, galactose and glucosamines, 7-8 phosphate groups and 8 disulfide bonds. After being transported from the blood to the egg white, most of the riboflavin (Vitamin B2) is stored in the egg white bound to an apoprotein called flavoprotein. One mole of apoprotein binds one mole of riboflavin, but this binding ability is lost when the protein is exposed to a pH below its isoelectric pH 4.2 [5]. It has antimicrobial properties due to depriving the microorganisms from its riboflavin content [50].
4.10. Ovoinhibitor
This trypsin inhibitor was discovered by Matsushima in 1958. While it is a Kazal-type inhibitor (like ovomucoid), ovoinhibitor functions as a multi-headed inhibitor and inhibits bacterial serine proteinase, fungal serine proteinase and mammalian chymotrypsin [5].
4.11. Cystatin
It is the third proteinase inhibitor in egg white (also called ficin-papain inhibitor). In contrast to ovomucin, cystatin is a small molecule (12.7 kDa) and it has no carbohydrates and a high thermal stability. The potential of their broad application in medical treatments has been reported in the literature, which includes antimicrobial and antiviral activities [83], the prevention of cerebral hemorrhage [84] and control of cancer cell metastasis [85].
4.12. Ovoglycoprotein
Ovoglycoprotein is an acidic glycoprotein with a molecular weight of 24.4 kDa. This protein contains hexoses 13.6%, glucosamine 13.8%, and N-acetylneuraminic acid 3%. The biological functions of ovoglycoprotein are still unclear [5].
5. Egg white bio peptides
5.1. Ovoalbumin peptide (Ovokinin)
Ovokinin, a vasorelaxing octapeptide derived from pepsin digest of ovalbumin, has been shown to significantly lower the systolic blood pressure of spontaneously hypertensive rats [86]. Oral vailability of ovokinin is improved after emulsification. When we eat whole egg, ovalbumin peptides will be released by the action of pepsin in the stomach, and the peptide will be instantly emulsified with egg yolk and effectively absorbed from the intestines.
A vasorelaxing peptide – ovokinin (2-7) – was isolated from chymotryptic digest of ovalbumin [87]. However, the mechanisms for the relaxation were different from ovokinin. More anti-hypertensive peptide was obtained by modifying the amino acid residues of ovokinin (2-7). The minimum effective dose of [Pro2, Phe3]-ovokinin (2-7) was about one-thirtieth of that of ovokinin (2-7). [Pro2, Phe3]-ovokinin (2-7) proved to be a potent anti-hypertensive peptide with little effect on normal blood pressure when administered orally [88].
5.2. Ovotransferrin peptides
The ovotransferrin antimicrobial peptide (OTAP-92) is a 92 amino acid cationic fragment of hen ovotransferrin located (109-299) in the N-lobe of ovotransferrin. The peptide OTAP-92 showed strong bactericidal activity against both Gram-positive
5.3. Ovomucoid and ovomucin peptides
A pepsin-digest of egg white ovomucoid was prepared to enhance digestibility and lower allergenicity [90]. A highly glycosylated peptide fragments (220 and 120 kDa) was separated from pronase digest of avian egg white ovomucin; It was derived from the β-subunit. Both fragments inhibited the growth of tumors [91].
5.4. Egg white peptides (Runpep®)
Egg white hydrolysate (Runpep®) has been produced by standardized technology to provide a highly nutritive source of peptides. Runpep® contains all essential amino acids with amino acid score of 100 [5, 50]. It is rich in branched chain amino acids (BCAA); these are the essential amino acids leucine, isoleucine, and valine. BCAA's are of special importance for athletes because they are metabolized in the muscle, rather than in the liver. Moreover, it is a rich source of sulpher containing amino acids as methionine and cysteine. It is in the form of small peptides (less than 3000 Da) and contains more than 91% protein providing easily absorbable amino acids source (Figure 8). An
The hydrolysate of egg white with pepsin was found to exhibit a strong angiotensin I–converting enzyme (ACE) inhibitory activity in vitro [95]. Other work reports the antioxidant activity of peptides produced by pepsin hydrolysis of egg white; four peptides included in the protein sequence of ovalbumin possessed radical scavenging activity higher than that of Trolox. The combined antioxidant and ACE inhibition properties make it a very useful multifunctional preparation for the control of cardiovascular diseases, particularly hypertension. No correlation was found between antioxidant and ACE inhibitory activities of pepsin digest of egg white [96].
5.5. Lysozyme peptides
Lysozyme is known to have a variety of folding topologies around the active site cleft [97]. Enzymatic hydrolysis of lysozyme is a novel technology that uses proteolytic enzymes for hydrolyzing native lysozyme to produce potent antimicrobial peptides that hidden within its folds. Lysozyme was digested by different proteolytic enzymes, such as clostripain [58, 60], pepsin, and trypsin [97, 98, 99]. All these researchers proved that the resulting peptides lost the enzymatic activities of lysozyme, but exhibited strong bactericidal activities against both Gram-negative (
Consumers are increasingly demanding food that is free from pathogens, but with less preservatives and additives. As a response to these conflicting demands, current trends in the food industry include the investigation of alternative natural preservative in foods. Six Gram-negative bacteria (
6. Egg shell membrane bio proteins
The egg shell membrane has been thought to be beneficial in the treatment of some injuries. For example, in Japan, when Sumo wrestlers get flesh abrasions, they will often peel the egg membrane from the egg shell and cover their injuries. They believe that it facilitates their recovery. Peptides product which are stable in water have been prepared from hydrolyzed egg membrane. The effects of this egg shell membrane protein on cell growth have been studied. The growth of normal human skin fibroblasts on egg membrane protein-coated tissue cultures increased in relation to increasing egg membrane protein concentration.
The egg shell membranes contain several bacteriolytic enzymes (e.g. lysozyme and N-acetylglucosaminidase) and other membrane components which may alter the thermal resistance of Gram-positive and Gram-negative bacterial pathogens (Salmonella Enteritidis, Escherichia coli 0157:H7, Listeria monocytogenes and Staphylococcus aureus).
The presence of hydroxyproline in hydrolysates of the egg shell membrane layers has suggested that the membrane layers contain collagen [103]. This has been confirmed using biochemical and immunological tests. It has been established that about 10% of the total proteinaceous content of the membrane structure of an egg shell is collagen. The outer shell membrane contains predominately Type I collagen and the inner shell membrane contains Types I and V collagen. In addition, Type X collagen has been found in both the inner and outer shell membranes using immunohistochemical analysis. It is important to recognize the presence of collagen in egg shell membranes because of its potential value.
7. Egg shell bio proteins
Different Non-collagenous proteins have been identified in the organic matrix of the hen’s egg shell. Ovocleidin-17 is a soluble matrix protein component and distributed in palisade and mammillary layers [104].
Ovocalyxin-32 has been identified as a novel 32-kDa protein. It is expressed at high levels in the uterine and isthmus regions of the oviduct, and concentrated in the eggshell. In the eggshell, ovocalyxin-32 localizes to the outer palisade layer, the vertical crystal layer, and the cuticle of the eggshell, in agreement with its demonstration by Western blotting at high levels in the uterine fluid during the termination phase of eggshell formation. Ovocalyxin-32 is therefore identified as a novel protein synthesized in the distal oviduct where hen eggshell formation occurs [105].
Osteopontin, a phosphorylated bone glycoprotein involved in formation and remodeling of the mineralised tissue, has also been demonstrated in the hen egg shell. Gene expression for this protein has been shown to be higher during the period of calcification [106].
Ovalbumin, lysozyme and ovotransferrin, as egg white proteins, have been identified in hen’s egg shell. The organic matrix also contains several proteoglycan molecules [107].
Chicken eggshell powder has been proposed as an attractive source of calcium for human health to increase bone mineral density in an elderly population with osteoporosis. However, factors affecting calcium transport of eggshell calcium have not yet been evaluated. Chicken eggshell contains about 1.0% (w/w) matrix proteins in addition to a major form of calcium carbonate (95%, w/w). It was found that soluble eggshell matrix proteins remarkably enhance calcium transport using in vitro Caco-2 cell monolayers grown on a permeable support. The total calcium transport across Caco-2 monolayers showed an increase of 64% in the presence of 100 microg/well soluble eggshell matrix proteins. The active enhancer with a molecular mass of 21 kDa was isolated by reversed phase high-performance liquid chromatography and did not match to any previously identified protein. The N-terminal sequence was determined to be Met-Ala-Val-Pro-Gln-Thr-Met-Val-Gln. The possible mechanisms of eggshell matrix protein-mediated increase in calcium transport and the potential significance of eggshell calcium as a nutraceutical are discussed [108].
Experimental and clinical studies performed to date have shown a number of positive properties of eggshell powder, such as antirachitic effects in rats and humans. A positive effect was observed on bone density in animal models of postmenopausal osteoporosis in ovariectomized female rats. In vitro eggshell powder stimulates chondrocyte differentiation and cartilage growth. Clinical studies in postmenopausal women and women with senile osteoporosis showed that eggshell powder reduces pain and osteoresorption and increases mobility and bone density or arrests its loss. The bioavailability of calcium from this source, as tested in piglets, was similar or better than that of food grade purified calcium carbonate. Clinical and experimental studies showed that eggshell powder has positive effects on bone and cartilage and that it is suitable in the prevention and treatment of osteoporosis [109].
References
- 1.
The role of eggs in American diets: health implications and benefits. In: Watson R., editor. Eggs and health promotion. Iowa: Blackwell Publishing Co.Kerver J. M Park Y Song W. O 2002 9 18 - 2.
Hasler C. M The changing face of functional foods. Journal American College of Nutrition2000 499S EOF 506S EOF - 3.
The nutritive value of theWatkins B. A egg. In: Stadelman WJ, Cot terill OJ, editors. Egg science and technology. New York: The Haworth Press Inc.1995 177 194 - 4.
Shin J. H Yang M Nam S. W Kim J. T Myung N. H Bang W. G Roe I. H Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clinical Diagnostic Laboratory of Immunology2002 9 1061 1066 - 5.
General chemical composition of hen eggs. In: Yammamoti T, Juneja LR, Hatta H, Kim M, editors. Hen eggs: Their basic and applied science. Boca Raton: CRC Press.Sugino H Nitoda T Juneja L. R 1997 13 24 - 6.
Shinohara K Fukushima T Suzuki M Tsutsumi M Kobori M Kong Z. L Effect of some constituents of chicken egg yolk lipoprotein on the growth and IgM production of human-human hybridoma cells and other human-derived cells. 1993 11 149 154 - 7.
Iron (III)-phosphoprotein charts: Stoichiometricequilibrium constant for interaction of iron (III) and phosphoserine residues of phosvitin and casein. BiochemistryHegenauer J Saltmann P Nace G 1979 18 3865 3879 - 8.
Nakamura S Ogawa M Nakai S Kato A Kitts D. D Antioxidant activity of a Maillard-type phosvitin-galactomannan conjugate with emulsifying properties and heat stability Journal of Agriculture Food Chemistry1998 46 3958 3963 - 9.
Sattar Khan MA Nakamura S, Ogawa M, Akita E, Azakami H, Kato A.Bactericidal action of egg yolk phosvitin against Escherichia coli under thermal stress Journal of Agriculture Food Chemistry2000 48 1503 1506 - 10.
Williams T Serum proteins and the livetins of hen’s egg yolk. Biochemistry Journal1962 83 346 355 - 11.
IgY technology for human health: Antimicrobial activities of IgY preparations against foodborne pathogens. The 225th ACS National Meeting, New Orleans, LA.:Sunwoo H. H Sim J. S 2003 - 12.
Hatta H Tsuda K Akachi S Kim M Yamamoto T Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biotechnology and Biochemistry1993 57 450 454 - 13.
Sun S Mo W Ji Y Lius S Preparation and mass spectrometric study of egg yolk antibody (IgY) against rabies virus, Rapid Communications in Mass Spectrometry2001 15 708 712 - 14.
Comparison of antibody production to human interlukin-6 (IL-6) by sheep and chickens. Journal of Immunological MethodsWoolley J. A Landon J 1995 187 253 265 - 15.
Shimizu M Nagashima H Sano K Hashimoto K Ozeki M Tsuda K Molecular stability of chicken and rabbit immunoglobulin G. Biotechnology and Biochemistry1992 56 270 274 - 16.
Campbell R. D Dodds A. W Porter R. R The binding of human complement component C4 to antibody-antigen aggregates. Biochemistry Journal1980 189 67 80 - 17.
Fischer M Hlinak A The lack of binding ability of staphylococcal protein A and streptococcal protein G to egg yolk immunoglobulins of different fowl species. Berl Munch Tierarztl Wochenschr2000 113 94 96 - 18.
Larsson A Karlsson-parra A Sjoquist J Use of chicken antibodies in enzyme immunoassays to avoid interferences by rheumatoid factors Clinical Biochemistry1991 37 411 414 - 19.
Interaction of two GPIIb/IIa monoclonal antibodies with platlet Fc receptor (Fc gamma RII). British Journal of HaematologyRubinstein E Kouns W. C Jennings L. K Boucheix C Carroll R. C 1991 87 80 86 - 20.
Narat M Production of antibodies in chickens 2003 41 259 267 - 21.
Eggs vital to human and animal medicine. World PoultryZeidler G 1998 14 33 34 - 22.
Sarker S. A Casswall T. H Juneja L. R Hoq E Hossain I Fuchs G. J Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. 2001 32 19 25 - 23.
Yang H Jin Z Yu Q Yang T Wang H Liu L The selective recognition of IgY for digestive cancers. 1997 13 85 90 - 24.
Helicobacter pylori. Clinical Microbiology ReviewsDunn B. E Cohen H Blaser M J 1997 10 720 741 - 25.
Blaser M J Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. 1990 161 626 633 - 26.
Parsonnet J Hansen S Rodriguez L Gleb A. B Warnke R. A Jellum E Orentreich N Vogelman J. H Friedman G. D Helicobacter pylori infection and gastric lymphoma. 1994 330 1267 1271 - 27.
Helicobacter pylori. American Journal of GastroenterolologyMarshall B. J 1994 89 116 128 - 28.
Chandan R. C Enhancing market value of milk by adding cultures 1999 82 2245 2256 - 29.
Development of anti-Helicobacter pylori urease IgY and its application for food product. Food Processing and Ingredients (in Japanese)Yamane T Saito Y Takizawa S Goshima H Kodama Y Horie N Kim M 2003 - 30.
Delta [sup 13] C-urea breath test value is a useful indicator for Helicobacter pylori eradication in patients with functional dyspepsia. Journal of Gastroenterology and HepatologyChang Y Min S Kim K Han Y Lee J 2003 - 31.
Effect of anti-Helicobacter pylori urease antibody (IgY) as a food ingredient on the decrease of H. pylori in the stomach of humans infected with H. pylori. in Taiwanese)Chen J. P Chang M. C 2003 408 EOF 414 EOF - 32.
Egg Yolk Immunoglobulin (IgY) on Helicobacter pylori in Humans. Journal of Dairy ScienceHorie K Horie N Abdou A. M Yang J. O Yun S. S Chun H. N Park C. K Kim M Hatta H 2004 - 33.
Michetti P Dorta G Wiesel P. H Brassart D Verdu E Herranz M Felley C Porta N Rouvet M Blum A. L Corthésy-theulaz I Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans 1999 203 EOF 209 EOF - 34.
Thomson ABR, Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the suppression of Helicobacter pylori infection. DigestionWendakoon C. N 2002 - 35.
Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans. Antimicrobial ChemotherapySakamoto I Igarashi M Kimura K Takagi A Miwa T Koga Y 2001 - 36.
Bosschaert MAR, Pot RGJ, Vandenbroucke-Grauls CMJE, Kusters JG.Cats A Kuipers E. J Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects Alimentary Pharmacology and Therapeutics2003 429 EOF 435 EOF - 37.
Egg yolk antibody and its application. Biotechnology and Bioprocess EngineeringKim M Higashiguchi S Iwamoto Y Yang H. C Cho H. Y Hatta H 2000 - 38.
Production of anti- Helicobacter pylori urease-specific immunoglobulin in egg yolk using an antigenic epitope of H. pylori urease. Journal of Medical MicrobiologyShin J. H Roe I. H Kim H. G 2004 - 39.
Dental caries vaccines: Prospects and concerns. Critical Reviews in Oral Biology and MedicineSmith D. J 2002 - 40.
Role of Streptococcus mutans in human dental decay. Microbiological ReviewsLoesche W. J 1989 - 41.
Virulence factors of Streptococcus mutans and dental caries prevention. Journal of Dental ResearchHamada S Koga T Ooshima T 1984 - 42.
Protection of rats against dental carries by passive immunization with hen-egg-yolk antibody (IgY). Journal of Dental ResearchOtake S Nishihara Y Makimura M Hatta H Kim M Yamamoto T Hirasawa M 1991 - 43.
Passive immunization against dental plaque formation in humans: Effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries ResearchHatta H Tsuda K Ozeki M Kim M Yamamoto T Otake S Hirasawa M Katz J Childers N. K Michalek S. M 1997 - 44.
Advances in IgY applications: characteristics of specific egg yolk immunoglobulin against influenza virus, Page 72 in Proc. 16thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry (in Japanese), Hiroshima, Japan:Nakamura T Umeda K Kusonoki S Arai J Namiki H 2004 - 45.
Suppressive effect of Topical Specific Egg Yolk Immunoglobulin (IgY) on Propionibacterium acnes in Acne Vulgaris. Sci. J. Al-Azhar Med. Fac. (girls).Fathy G Abdel-raheem S. M Abdou A. M Horie M Kim M Suzuki H 2007 - 46.
Preparation of novel functional oligophoshopeptides from hen egg yolk phosvitin. Journal of Agricultural and Food ChemistryJiang B Mine M 2000 - 47.
Effect of egg yolk proteins on the longitudinal bone growth in rat, Page 200 in Proc. 16thAnnual meeting Jpn. Soc. Biosci. Biotechnol. & Agrochem. (in Japanese), Hiroshima, Japan:Leem K. H Kim M. G Kim H. K Oi Y Kim M 2004 - 48.
Effect of egg yolk proteins on the longitudinal bone growth of adolescent male rat, Bioscience Biotechnology and BiochemistryLeem K. H Kim M. G Kim H. M Kim M Lee Y. J Kim H. K 2004 - 49.
The effect of hen egg yolk peptide on bone growth, 17thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry (in Japanese), Hokkaido, Japan:Oi Y Ji M. Y Leem K. H Cho S. W Kim M 2005 - 50.
Insight into the structure-function relationships of ovalbumin, ovotransferrin, and lysozyme. In: Yamamoto T, Juneja LR, Hatta H, Kim M, editors. Hen Eggs: Their basic and applied science. New York: CRC press, Inc.Ibrahim H. R 1997 - 51.
Emulsifying and structural properties of ovalbumin. Journal of Agricultural and Food ChemistryMine Y Noutomi T Haga N 1991 - 52.
The complete amino-acid sequence of hen ovalbumin, European Journal of Biochemistry/FEBSNisbet A. D Saundry R. H Moir A. J Fothergill L. A Fothergill J. E 1981 - 53.
Gettins PGW Patston PA, Olson ST. Serpins: Structure, Function and Biology, LandersRG. Austin, TX:1996 - 54.
Structure and properties of ovalbumin. Journal of Chromatography BHuntington J. A Stein P. E 2001 - 55.
Ovotransferrin. In: Naidu AS, editor. Natural food antimicrobial systems. New York: CRS Press, Inc.Ibrahim H. R 2000 - 56.
MacGillivrays TA. Association of the two lobes of ovotransferrin is a prerequisite for receptor recognition: Studies with recombinant ovotransferrins. Biochemistry JournalMason A. B Woodworth R. C Oliver R. W Green B. N Lin L. N Brandts J. F Savage K. J Tam B. M 1996 - 57.
Conalbumin in the treatment of acute enteritis in the infant. Journal Tissue ReactionsCorda R Biddau P Corrias A Puxeddu E 1983 - 58.
Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model molecules. Current Pharmacological DesignIbrahim H. R Aoki T Pellegrini A 2002 - 59.
Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Critical Reviews in MicrobiologyMasschalck B Michiels C. W 2003 - 60.
Identification and isolation of bactericidal domain in chicken egg white lysozyme. Journal of Applied MicrobiologyPellegrini A Bramaz T. N Klauser S Hunziker P Von Fellenberg R 1997 - 61.
Reevaluation of the effect of lysozyme on Escherichia coli employing ultrarapid freezing followed by cryoelectron microscopy or freeze substitution. Microscopy Research and TechniqueWild P Gabrieli A Schraner E. M Pellegrini A Thomas U Frederik P. M Stuart M. C Vonfellenberg R 1997 - 62.
Antimicrobial effects of lysozyme against Gram-negative bacteria due to covalent binding of palmitic acid. Journal of Agricultural and Food ChemistryIbrahim H. R Kato A Kobayashi K 1991 - 63.
Lipophilization of lysozyme by short and middle chain fatty acids. Journal of Agricultural and Food ChemistryLiu S. T Sugimoto T Azakami H Kato A 2000 - 64.
New approach to improve the gelling and surface functional properties of dried egg white by heating in dry state. Journal of Agricultural and Food ChemistryKato A Ibrahim H. R Watanabe H Honma K Kobayashi K 1989 - 65.
Enzyme activity of lysozyme-dextran complex prepared by high-pressure treatment. Food Science and Technology InternationalNakamura N. K Furukawa N Matsuoka M Takahashi T Yamanaka Y 1997 - 66.
Rapid formation of biologically active neoglycoprotein from lysozyme and xyloglucan hydroysates throughnaturally occurring Maillard reaction. Journal of Food Science and NutritionNakamura S Saito M Goto T Saeki H Ogawa M Gotoh M Gohya Y Hwang J. K 2000 - 67.
Lysozyme-glucose stearic acid monoester conjugate formed through the Maillard reaction as an antibacterial emulsifier. Journal of Agricultural and Food ChemistryTakahashi K Lou X. F Ishii Y Hattori M 2000 - 68.
Improvement in the yield of lipophilized lysozyme by the combination with Maillard-type glycosylation. NahrungLiu S. T Azakami H Kato A 2000 s407. - 69.
Separation, polymer formation and antibacterial activity of lysozyme. Polish Journal of Food and Nutrition SciencesKijowski J Lesnierowski G 1999 - 70.
Van den Berg G, Van Ginkel W. The use of lysozyme to prevent butyric fermentation in Gouda cheese. Voedingsmiddelen technlogieStadhouders J Stegink H 1987 - 71.
The association of lysozyme with casein. International Dairy JournalDe Roos A. L Walstra P Geurts T. J 1998 - 72.
Application of the enzyme lysozyme in brewing. Master Brewers. Association of American Technology Quart.Daeschel M. A Bruslind L Clawson J 1999 - 73.
Selective antibacterial properties of lysozyme for oral microorganisms. Infection and ImmunityLacono V. J Mackay B. J Dirienzo S Pollock J. J 1980 - 74.
El- A fluorimetric investigation of the binding of drugs to lysozyme. Journal of Pharmacy and PharmacologyNimr A Hardee G. E Perrin J. H 1981 - 75.
Immunostimulatory effects of dimerized lysozyme (KLP-602) on the nonspecific defense mechanisms and protection against furunculosis in salmonids. Veterinary Immunology and ImmunopathologySiwicki A. K Klein P Morand M Kiczka W Studnicka M 1998 - 76.
The mode of action of lysozyme as an immunoglobulin production stimulation factor. Biochimica and Biophysica ActaSugahara T Murakami F Yamada Y Sasaki T 2000 - 77.
Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme. Cancer Chemotherapy PharmacologySava G 1989 - 78.
Sialic acid-containing sugar chains of hen ovalbumin and ovomucoid. Carbohydrate ResearchYamashita K Tachibana Y Hitoi A 1984 - 79.
Allergenic activity of heated and ovomucoid-depleted egg white. Journal of Allergy and Clinical ImmunologyUrisu A Ando H Morita Y Wada E Yasaki T Yamada K Komada K Torii S Goto M Wakamatsu T 1997 - 80.
Binding of egg white proteins to viruses. Bioscience Biotechnology and BiochemistryTsuge Y Shimoyamada M Watanabe K 1996 - 81.
Cytotoxic effect of sialoglycoprotein derived from avian egg white ovomucin on the cultured tumor cell. Medicine and BiologyOhami H Ohishi H Yokota T Mori T Watanabe K 1993 - 82.
Avidin. Advances in Protein ChemistryGreen N. M 1975 - 83.
Protease inhibitors prevent the development of human rotavirus induced diarrhea in suckling mice. Microbiology and ImmunologyEbina T Tsukada K 1991 - 84.
Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS LettersAbrahamson M Dalboge H Olafsson I Carlsen S Grubb A 1988 - 85.
Anti-carcinogenic activity of protease inhibitors. In: Troll W, Kennedy AR, editors. Protease Inhibitors as Cancer Chemopreventive Agents. New York : Plenum Press.Kennedy A. R 1993 - 86.
Potentiation of the anthypertensive activity of orally administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidylcholine. Bioscience Biotechnology and BiochemistryFujita H Sasaki R Yoshikawa M 1995 - 87.
A novel anti-hypertensive peptide derived from ovalbumin induced nitric oxide-mediated vasorelaxation in an isolated SHR mesenteric artery. FEBS LettersMatoba N Usui H Fujita H Yoshikawa M 1999 - 88.
Designing potent derivatives of ovokinin (2-7), an anti-hypertensive peptide derived from ovalbumin. Bioscience Biotechnology and BiochemistryMatoba N Yamada Y Usui H Fujita H Nakagiri R Yoshikawa M 2001 - 89.
Identification of a distinct antibacterial domain within the N-lobe of ovotransferrin. Biochimica et Biophysica ActaIbrahim H. R Iwamori E Sugimoto Y Aoki T 1998 - 90.
Immunochemical and structural analysis of pepsin-digested egg white ovomucoid. Journal of Agricultural and Food ChemistryKovacs-nolan J Zhang J. W Hayakawa S Mine Y 2000 - 91.
Antitumor effects of pronase treated fragments, glycopeptides, from ovomucin in hen egg white in a double grafted tumor system. Journal of Agricultural and Food ChemistryWatanabe K Tsuge Y Shimoyamada M Ogama N Ebina T 1998 - 92.
Anti-thrombotic action of egg white peptides. Page 198 in Proc. 16thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry (in Japanese), Hiroshima, Japan.Kittaka R Cho H. J Choi S. H Kang H. C Choi S. A Jung Y. J Lee T. K Kim C. R Park H. J Kim M 2004 - 93.
Inhibitory effects of oligopeptides from hen egg white on both human platelet aggregation and blood coagulation. Archives in Pharmacology ResearchCho H. J Kittaka R Abdou A. M Kim M Kim H. S Lee D. H Park H. J 2009 - 94.
El- Pharmacologically active peptide derived from egg white with circulatory beneficial effects. 17thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry, Hokkaido, Japan.Mahmoudy A Kittaka R Okamoto K Shimizu Y Shiina T Takewaki T Kim M 2005 - 95.
Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food ProtectionMiguel M Recio J. A Gómez-ruiz M Ramos M Amos M López-fandiňo R 2004 - 96.
Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food ProtectionDávalos A Miguel M Bartolomé B López-fandiňo R 2004 - 97.
Processing of Lysozyme at distinct loops by pepsin: A novel action for generating multiple antimicrobial peptide motifs in the newborn stomach. Biochimica et Biophysica Acta (BBA)Ibrahim H. R Inazaki D Abdou A. M Aoki T Kim M 2005 - 98.
A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. Journal of Biological ChemistryIbrahim H. R Thomas U Pellegrini A 2001 - 99.
Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. Journal of Agricultural and Food ChemistryMine Y Lauriau S Ma F 2004 - 100.
Lysopep: a lysozyme peptide preparation has an exaggerated antimicrobial activity against Gram-negative bacteria, Page 226 in Proc. 16thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry, Hiroshima, Japan.Abdou A. M Higashiguchi S Aboueleinin A Kim M Ibrahim H. R 2004 - 101.
Antimicrobial peptides derived from hen egg lysozyme with inhibitory effect against Bacillus species. Food ControlAbdou A. M Higashiguchi S Aboueleinin A. M Kim M Ibrahim H. R 2007 - 102.
A marvelous inhibitory effect of lysozyme peptides preparation against Bacillus species. Page 221 in Proc. 15thAnnual meeting Japanese Society of Bioscience Biotechnology and Agrochemistry, Yokohama, Japan.Abdou A. M Higashiguchi S Kim M Ibrahim H. R 2003 - 103.
Chemical composition of chicken eggshell and shell membranes. Poultry ScienceNakano T Ikawa N. I Ozimek L 2003 - 104.
Tsang CPW, Courtney M, Hill V, Narbaitz R. Purification and immunochemistry of a soluble matrix protein of the chicken eggshell (ovocleidin-17). Calcified Tissue InternationalHincke M. T 1995 - 105.
Ovocalyxin-32, a novel chicken eggshell matrix protein. Journal of Biological ChemistryGautron J Hincke M. T Mann K Panhéleux M Bain M Mckee M. D Solomon S. E Nys Y 2001 - 106.
Involvement of osteopontin in egg shell formation in the layingchicken. Matrix BiologyPines M Knopov V Bar A 1994 - 107.
Eggshells are shaped by a precise spatio-temperal arrangement of sequentially deposited macromolecules. Matrix BiologyFerandez M. S Araya M Arias J. L 1997 - 108.
Chicken eggshell matrix proteins enhance calcium transport in the human intestinal epithelial cells, Caco-2. Journal of Agricultural and Food ChemistryDaengprok W Garnjanagoonchorn W Naivikul O Pornsinlpatip P Issigonis K Mine Y 2003 - 109.
Eggshell calcium in the prevention and treatment of osteoporosis. International Journal of Clinical PharmacologyRovensky J Stancikova M Masaryk P Svik K Istok R 2003